Amlogenyx (Seed)

Funding Details

Awarder

Inbox

Date Award

August 02, 2024

Vertical

Biotechnology

Funding URL

View Funding Page

Funding Amount:

$14,000,000

---

Company Info

Founders

Emil Kakkis

Company Description

Amlogenyx research centers around an enzyme called protective protein/cathepsin A, or PPCA, which can break up a form of amyloid beta, the protein many consider responsible for Alzheimer's debilitating effects.

Market

Alzheimer's Disease Treatment

Location

Novato, California, USA

Coinvestors

GordonMD Global Investments

---

Links

• Website